Wnt Signalling & Metastasis

About us

Our overall aim is to understand the key processes in epithelial to mesenchymal transition (EMT) and metastasis, in order to identify targets for novel cancer therapies.

Our group focuses on an important signalling pathway involved in metastasis and EMT, the Wnt signalling pathway. We are particularly interested in investigating the epigenetic regulation of a number of key proteins involved in this pathway, and understanding their role in the context of ovarian, breast and colorectal cancer.

Team

People related to this group

• 

  Dr Caroline Ford

  Lecturer

• Ms Eve Jary

  Research Assistant

• Ms Gaya Punnia-Moorthy

  Masters student

• Mr Sean Ma

  PhD student

• Ms Claire Henry

  Honours Student

• Mr Rupert Higgins

  Honours Student

Collaborators

Collaborators related to this group

• Dr Viola Heinzelmann-Schwarz, Gynaecological Cancers Group, UNSW

• Dr Luke Hesson, Molecular & Cellular Oncology, UNSW

Prof William Rawlinson
Virology Research Laboratory, Prince of Wales Hospital

Grants & Funding

Grants

2012: UNSW Faculty Research Grant - $20,000. The role of the Ror2 Wnt receptor tyrosine kinase in colorectal cancer

2011: Cure Cancer Australia Grant #1008633 - $90,000. Targeting the Wnt signalling pathway - a new metastatic and epigenetic therapy for ovarian cancer

2010-2012: NHMRC Project Grant #630458 - $318,750 . Wnt-5a signaling – a novel therapy for triple negative and Tamoxifen resistant breast cancer patients

2007-2011: NHMRC CJ Martin Fellowship #466005 - $314,589

Group contacts

Contacts for this group

• 

  Dr Caroline Ford

  Lecturer